Subject(s)
Porokeratosis , Cholesterol , Humans , Lovastatin , Ointments , Porokeratosis/diagnosis , Porokeratosis/drug therapyABSTRACT
Ischemic stroke is a complex multifactorial disorder. Anticoagulation is a growing research area, with the main goal of preventing systemic embolization and stroke. We report the case of a 41-year-old woman with antiphospholipid syndrome who was unsuccessfully treated with Dabigatran, a new oral anticoagulant, as she developed a major stroke involving the right carotid artery, due to deep venous thrombosis with pulmonary embolism. We therefore suggest a closer monitoring of the safety and efficacy of dabigatran. Moreover, in the presence of multifactorial causes of pro-coagulation, we believe that warfarin should remain the mainstay of oral anticoagulation.
Subject(s)
Antiphospholipid Syndrome/drug therapy , Antithrombins/adverse effects , Antithrombins/therapeutic use , Dabigatran/adverse effects , Dabigatran/therapeutic use , Stroke/drug therapy , Stroke/prevention & control , Warfarin/therapeutic use , Abortion, Spontaneous , Acenocoumarol/therapeutic use , Adult , Antithrombins/administration & dosage , Carotid Arteries/diagnostic imaging , Carotid Arteries/pathology , Computed Tomography Angiography , Dabigatran/administration & dosage , Female , Follow-Up Studies , Humans , Product Surveillance, Postmarketing/methods , Pulmonary Embolism/complications , Pulmonary Embolism/diagnostic imaging , Stroke/diagnostic imaging , Stroke/etiology , Treatment Outcome , Venous Thrombosis/complications , Venous Thrombosis/diagnostic imagingABSTRACT
Hypersexuality, also referred to as sexually inappropriate behavior and sexual disinhibition, involves persistent, uninhibited sexual behaviors directed at oneself or at others, sometimes associated with neurodegenerative disorders. Choline is a water-soluble essential nutrient, used as a dietary supplement in different diseases. This report was aimed at considering choline intake as a possible cause of iatrogenic hypersexuality. After an evaluation, a 79-year-old man affected by memory loss was diagnosed with mild cognitive impairment and treated with oral choline. After 6 weeks of regular choline assumption, the patient showed a pathological increase in libido with sexual urges. As choline was withdrawn, the hypersexuality disappeared within 5 days. Since hypersexuality may be an underreported and overlooked adverse effect of drugs and dietary supplements acting on the cholinergic pathway, this should be considered when treating and counselling patients with inappropriate sexual behavior.
